<DOC>
	<DOCNO>NCT00426452</DOCNO>
	<brief_summary>This study determine effect acidic drug proton-pump inhibitor pharmacokinetics Vatalinib fast feed condition .</brief_summary>
	<brief_title>A Drug-drug Interaction Study Oral 1250 mg Vatalinib Administered Under Fasting Fed Conditions With Proton-pump Inhibitor Healthy Sterile Postmenopausal Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Inclusion criterion Healthy female Surgically sterile postmenopausal At least weight 50 kg body mass index ( BMI ) â‰¤33.0 Nonsmokers smoke 25 cigarette less per day Exclusion criterion Use certain prescription counter drug Having receive investigational drug within 30 day prior dose Donation plasma donation loss whole blood prior administration study medication Any clinically significant laboratory test Abnormal cardiac function A positive test HIV , Hepatitis B C A positive alcohol test drug test Known allergy Vatalinib Omeprazole Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Vascular endothelial growth factor receptor ( VEGF-R ) tyrosine kinase inhibitor</keyword>
	<keyword>Vatalinib</keyword>
	<keyword>Proton-pump inhibitor</keyword>
	<keyword>Omeprazole</keyword>
	<keyword>Healthy Postmenopausal Female Volunteers</keyword>
</DOC>